121 BIBLIOGRAFIA
1. Accili, D. and Arden, K. C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117, 421-426
2. Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 2003; 555:597-600.
3. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B.
Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997;
53:1649-57.
4. Aldini G, Carini M, Piccoli A, Rossoni G, Facino RM. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidence for cardio-protection. Life Science 2003; 73:2883- 98.
5. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Rad Biol Med 2000;28:463-99.
6. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. Ischemia/reperfusion injury. J Surg Res. 15;105(2):248-58. 2002 Jun.
7. Anaya-Prado R, Toledo-Pereyra LH. The molecular events underlying ischemia/reperfusion injury.Transplant Proc. 2002; 34(7):2518-9.
8. Anderson RM, Latorre-Esteves M, Neves AR, Lavu S, Medvedik O, Taylor C, Howitz KT, Santos H, Sinclair DA.Yeast life-span extension by calorie restriction is independent of NAD fluctuation. Science. 2003; 302(5653):2124-6. Epub 2003 Nov 6
9. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 268:2764–277238.
10. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81(Suppl. 1):317S-25S.
11. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, Estrela JM. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med. 2002;
33(3):387-98.
122
12. Aumont V, Krisa S, Battaglia E, Netter P, Richard T, Merillon JM, Magdalou J, Sabolovic N. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human.
Arch Biochem Biophys. 2001; 393(2):281-9.
13. Aviram M, Fuhrman B, Keidar S, Maor I, Rosenblat M, Dankner G, Brook G. Platelet- modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation. J Clin Chem Clin Biochem. 1989; 27(1):3-12.
14. Azzi A, Davies KJA, Kelly F. Free radical biology: terminology and critical thinking. FEBS Lett 2004; 558:3-6.
15. Balaban, R. S., Nemoto, S. and Finkel, T. Mitochondria, oxidants, and aging. Cell 2005;
120, 483-495
16. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One. 2008; 3(6):e2264.
17. Barthel, A., Schmoll, D. and Unterman, T. G. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 2005; 16, 183-189.
18. Bastianetto S, Zheng WH, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol. 2000; 131:711–720.
19. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444:337–342.
20. Bergeron R, Ren JM, Cadman KS, Moore IK, Perret P, Pypaert M, Young LH, Semenkovich CF, Shulman GI. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab. 2001;
281(6):E1340-6.
21. Berne Robert M., Levy Matthew N., “Principi di fisiologia”, seconda edizione, casa editrice Ambrosiana, 2001.
123
22. Bertelli A.A.E, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A. Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res. 1996;16(4-5):77-81.
23. Bertelli A.A.E., Giovannini L, Stradi R, Bertelli A, Tillement JP. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React. 1996; 18(2-3):67-71.
24. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001; 90:157-77.
25. Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A, Easlon EJ, Lin SJ, Guarente L.Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 2006; 4(2):31.
26. Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005; 280:17187–17195.
27. Bors W, Michel C, Stettmaier K. Structure-activity relationships governing antioxidant capacities of plant polyphenols. Methods Enzymol 2001; 335:166-80.
28. Brown V. D., and Gallie B. L. The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation. Mol. Cell. Biol. 2002; 22:1390–
1401.
29. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF.
Science. 2001; 294(5545):1337-40.
30. Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran, H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303, 2011–2015.
31. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci. 2004; 29:18-24.
32. Carr AC, McCall MR, Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol. 2000;
20(7):1716-23.
124
33. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, TellisV, Devarajan P. Activation of mitochondrial apoptotic pathways in human renal allografts after ischemia reperfusion injury. Transplantation. 2003. 15;76(1):50-4.
34. Cattaneo L. (1986) “Compendio di anatomia umana”, seconda edizione, casa editrice Monduzzi.
35. Centeno JM, Orti M, Salom JB, Sick TJ, Pérez-Pinzón MA. Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices. Brain Res. 1999; 836(1- 2):62-9.
36. Chander V, Chopra K. Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg. 2005; 42(6):1198-205.
37. Chander V, Chopra K.Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats. Arch Med Res. 2006; 37(1):19-26.
38. Cheung P., C.D. Allis and P. Sassone-Corsi, Signaling to chromatin through histone modifications, Cell 2000, 103 pp. 263–271
39. Chien CT, Chang TC, Tsai CY, Shyue SK, Lai MK. Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis.
Am J Transplant. 2005; 5(6):1194-203.
40. Chuan-Ming H.,Volker H. Haase Sirtuins and Their Relevance to the Kidney. JASN 2010;
21:1620-1627.
41. Cohen, H.Y., Miller, C., Bitterman, K.J., Wall, N.R., Hekking, B., Kessler, B., Howitz, K.T., Gorospe, M., De Cabo, R. And Sinclair, D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390-392.
42. Connor HD, Gao W, Nukina S, Lemasters J, Mason RP, Thurman RG. Evidence that free radicals are involved in graft failure following orthotopic liver transplantation in the rat—an electron paramagnetic resonance spin trapping study. Transplantation. 1992; 54:199.
43. Craig, J.M. Heterochromatin—many flavours, common themes. Bioessays 2005; 27: 17-28.
44. Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation. 2002; 15;73(11):1693-700.
125
45. Das DK, Sato M, Ray PS, Maulik G, Engelman RM, Bertelli AA, Bertelli A.
Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res. 1999;
25(2-3):115-20.
46. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2007; 2(2):133-8.
47. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A. 2007; 104(17):7217-22. Epub 2007 Apr 16.
48. Denu JM. Linking chromatin function with metabolic networks: Sir2 family of NAD(+)- dependent deacetylases. Trends Biochem Sci. 2003; 28(1):41-8.
49. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA.Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.Science. 2009; 324(5932):1289-93.
50. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA.Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.
Science. 2009; 324(5932):1289-93.
51. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection.
Trends Neurosci. 2003; 26(5):248-54.
52. Donovan JL, Waterhouse AL. Bioavailability of flavanol monomers. In: Rice-Evans C, Parker L (Ed.). Flavonoids in health and disease. New York: Marcel Dekker; 2003. p. 413- 40.
53. Dyck J.R.B., Lopaschuk G.D. Malonyl CoA control of fatty acid oxidation in the ischemic heart. J. Mol. Cell. Cardiol. 2002; 34:1099–1109.
54. Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, Stringer SE, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro RJ, Fath-Ordoubadi F, Cartwright EJ, Lei M.Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. Am J Physiol Heart Circ Physiol. 2011; 301(4):H1487-95.
55. Elbling L, Weiss RM, Teufelhofer O, Uhl M, Knasmueller S, Schulte-Hermann R, Berger W, Micksche M. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J 2005; 19(7):807-9.
126
56. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ.C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107(1):43-54.
57. Esson ML, Schrier RW. Diagnosis and treatment of acute tubular. Ann Intern Med. 2002 5;137(9):744-52.
58. Ferrero ME, Bertelli AE, Fulgenzi A, Pellegatta F, Corsi MM, Bonfrate M, Ferrara F, De Caterina R, Giovannini L, Bertelli A. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr. 1998; 68(6):1208-14.
59. Finkel T, Deng CX, Mostoslavsky R.Recent progress in the biology and physiology of sirtuins. Nature. 2009; 460(7255):587-91.
60. Fischer PM, Lane DP. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics.
Curr Med Chem 2000; 7:1213-45.
61. Frescas D, Valenti L, Accili D Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 2005; 280:20589–20595.
62. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene:
Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun. 1999; 260(1):273-9.
63. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Peyrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999; 32:279-86.
64. Giannakou, M.E. and Partridge, L. The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 2004; 14: 408-412.
65. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Filippi C, Bertelli A. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol. 2001; 37(3):262-70.
66. Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid Balance, Diuretic Use, and Mortality in Acute Kidney Injury. Clin J Am Soc Nephrol. 2011; 6(5):966-973.
127
67. Greer, E. L. and Brunet, A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005; 24, 7410-7425
68. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature. 2006;
444(7121):868-74.
69. Guarini M., Valutazione dello Stress Ossidativo sui livelli di Dolicolo e di altri antiossidanti di membrana. Tesi di Dottorato di ricerca in Biologia e Patologia dell’invecchiamento. 2008.
70. Hansen JC. Conformational dynamics of the chromatin fiber in solution: determinants, mechanisms, and functions. Annu Rev Biophys Biomol Struct. 2002;31:361-92.
71. Hao CM, Haase VH. Sirtuins and their relevance to the kidney. J Am Soc Nephrol. 2010;
21(10):1620-7.
72. Hardie DG, Salt IP, Hawley SA, Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J. 1999; 338:717-722.
73. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP- activated protein kinase system. FEBS Lett. 2003; 546(1):113-20.
74. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 201;25(18):1895-908.
75. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K, Itoh H. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun. 2008; 372(1):51-6.
76. Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol:
role of nitric oxide. Am J Physiol Heart Circ Physiol 2002; 282:H1988–H1995.
77. He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010;120(4):1056-68
78. Hertog MG, Bueno de Mesquita HB, Fehily AM, Sweetnam PM, Elwood PC, Kromhout D.
Fruit and vegetable consumption and cancer mortality in the Caerphilly Study. Cancer Epidemiol Biomarkers Prev 1996; 5:673-7.
128
79. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 1996; 50:63-71.
80. Holmes B.F., Kurth-Kraczek E.J., Winder W.W. Chronic activation of 5′-AMP-activated protein kinase increases GLUT4, hexokinase, and glycogen in muscle. J. Appl. Physiol.
1999; 87:1990–1995.
81. Hong KS, Park JI, Kim MJ, Kim HB, Lee JW, Dao TT, Oh WK, Kang CD, Kim SH.Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols. Toxicol Appl Pharmacol. 2012; 259(2):210-8.
82. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6.
83. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science. 2006; 314(5797):294-7.
84. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res. 2000; 47(3):549-55.
85. Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3- gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 2005; 113:660-9.
86. Huxley RR, Neil HAW. The relation between dietary flavonoid intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 2003;
57:904-8.
87. Imagawa J, Yellon DM, Baxter GF. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br J Pharmacol. 1999; 126:701–708.
88. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol (an insight with iNOS knockout mice). Am J Physiol Heart Circ Physiol. 2002; 282:H1996–H2003.
89. Ingram DK, Anson RM, de Cabo R, Mamczarz J, Zhu M, Mattison J, Lane MA, Roth GS.
Development of calorie restriction mimetics as a prolongevity strategy. Ann N Y Acad Sci.
2004; 1019:412-23.
129
90. Isemura M, Saeki K, Minami T et al. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Ann NY Acad Sci 1999; 878:629-31.
91. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275(5297):218-20.
92. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK.. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem. 2005; 280(17):17038-45.
93. Kahn BB, Alquier T, Carling D Hardie DG. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism. 2005; 1:15- 25.
94. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury. Int J Cardiol. 2002; 86(1):41- 59.
95. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.
J Am Soc Nephrol. 2001; 12(7):1434-47.
96. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S,Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol., 2002; 13: 806–816.
97. Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W. SIRT1 activation by resveratrol ameliorates cisplatin- induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol. 2011;
301(2):F427-35.
98. Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W. SIRT1 activation by resveratrol ameliorates cisplatin- induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol. 2011;
301(2):F427-35.
130
99. Kishino M, Yukawa K, Hoshino K, Kimura A, Shirasawa N, Otani H, Tanaka T, Owada- Makabe K, Tsubota Y, Maeda M, Ichinose M, Takeda K, Akira S, Mune M. Deletion of the kinase domain in death-associated protein kinase attenuates tubular cell apoptosis in renal ischemia-reperfusion injury. J Am Soc Nephrol. 2004; 15(7):1826-34.
100. Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM. Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 2008; 22(7):2185-97.
101. Kong An, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 2000; 23:1-16.
102. Koprinarova M, Markovska P, Iliev I, Anachkova B, Russev G. Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest. BMC Mol Biol. 2010; 11:49.
103. Kops, G. J., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W., Coffer, P. J., Huang, T. T., Bos, J. L., Medema, R. H. and Burgering, B. M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002; 419, 316-321.
104. Kucińska M, Piotrowska H, Murias M. Sirtuins--modulation of their activity as a novel therapeutic target. Pol Merkur Lekarski. 2010; 28(165):231-5.
105. Kuhnle G, Spencer JP, Chowrimootoo G, Schroeter H, Debnam ES, Srai SK, Rice-Evans C, Hahn U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide.
Biochem Biophys Res Commun. 2000; 272(1):212-7.
106. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes.
2006;55(1):120-7.
107. Kuzmichev, A., Margueron, R., Vaquero, A., Preissner, T.S., Scher, M., Kirmizis, A., Ouyang, X., Brockdorff, N., Abate-Shen, C., Farnham, P. et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.
Proc Natl Acad Sci USA 2005;102: 1859-1864.
131
108. Kwon YW, Masutani H, Nakamura H, Ishii Y, Yodoi J. Redox regulation of cell growth and cell death. Biol Chem 2003; 384:991-6.
109. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127(6):1109-22.
110. Lambert JD, Hong J, Yang G, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr. 2005; 81(Suppl):
284S-91S.
111. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci USA 2000; 97:5807–5811.
112. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA,Minucci S, Pelicci PG, Kouzarides T Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.
EMBO J 2002; 21:2383–2396.
113. Laughton MJ, Evans PJ, Moroney MA, Hoult JRS, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives:
relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991; 42:1673-81.
114. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T.A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.Proc Natl Acad Sci U S A. 2008;105(9):3374-9.
115. Li H, Xia N, Förstermann U. Review Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide. 2012; 26(2):102-10.
116. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010;
38(6):864-78.
117. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010;
38(6):864-78.
132
118. Lu Z, Xu S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 2006;
58(11):621-31.
119. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, GuW. Negative control of p53 by Sir2_promotes cell survival under stress. Cell 2001; 107:137–148 39. 65.
120. Luximon-Ramma A, Bahorun T, Soobratee M, Aruoma OI. Antioxidant activities of phenolic, proanthocyanidin and flavonoid components in extracts of Cassia fistula. J Agric Food Chem 2002; 50:5042-7.
121. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001;
15(20):2675-86.
122. Manach C, Scalbert A, Morand C, Rémésy C, Jimenez L. Polyphenolis: food sources and bioavailability. Am J Clin Nutr 2004; 79:727-47.
123. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81(Suppl):230S-42S.
124. Masoro EJ. Caloric restriction and aging: an update. Exp Gerontol. 2000; 35(3):299-305.
125. Mcburney, M.W., Yang, X., Jardine, K., Hixon, M., Boekelheide, K., Webb, J.R., Lansdorp, P.M. And Lemieux, M. The mammalian SIR2 alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 2003; 23: 38-54.
126. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change?
127. Meyer JW, Schmitt ME. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett. 2000; 472(1):1-4.
128. Miatello R, Vázquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats.Am J Hypertens. 2005; 18(6):864-70.
129. Michishita, E., Park, J.Y., Burneskis, J.M., Barrett, J.C. And Horikawa, I. Evolutionarily Conserved and Nonconserved Cellular Localizations and Functions of Human SIRT Proteins. Mol Biol Cell 2005; 16: 4623-4635.
133
130. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferré P, Birnbaum MJ, Stuck BJ, Kahn BB. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004; 428(6982):569-74.
131. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995; 76:7379.
132. Mittnacht S. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 1998; 8:21–27.
133. Molitoris BA, Sutton TA Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int., 2004; 66(2):496-9.
134. Monasterio A, Urdaci MC, Pinchuk IV, Lopez-Moratalla N, Martinez-Irujo JJ. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain- dependent pathways. Nutr Cancer 2004; 50:90-100.
135. Morris KC, Lin HW, Thompson JW, Perez-Pinzon MA. Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab. 201;31(4):1003-19.
136. Motta, M.C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., Mcburney, M. And Guarente, L. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116: 551-563.
137. Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Méneur C, Permutt MA, Imai S.Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005; 2(2):105-17.
138. Mueller So, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 2004; 80:14-25.
139. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int. 1992; 42(4):1017-9.
140. Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, Turner AH, Mann NJ, Sinclair AJ. Dietary flavanols and procyanidin oligomers from cocoa (Teobroma cacao) inhibit platelet function. Am J Clin Nutr 2003; 77:1466-73.
141. Naasani I, Oh-Hashi F, Oh-Hara T et al. Blocking telomerase by dietary polyphenols is a
134
major mechanisms for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 2003; 63:824-30.
142. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell. 2008; 134(2):329-40.
143. Nemoto, S. and Finkel, T. Redox regulation of forkhead proteins through a p66shc- dependent signaling pathway. Science 2002; 295, 2450-2452.
144. Nihei T, Miura Y, Yagasaki K. Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sci. 2001; 68(25):2845-52.
145. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba MO. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science. 2005;
310(5746):314-7.
146. North BJ, Verdin E.Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004;5(5):224.
147. O’Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O’Brien NM, Williamson G.
Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2). Mutat Res 2004;
551:245-54.
148. Oak MH, El Bedoui J, Anglard P, Schini-Kerth VB. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 2004; 110:1861-7.
149. Oberbauer R, Schwarz C, Regele HM, Hansmann C, Meyer TW, Mayer G. Regulation of renal tubular cell apoptosis and proliferation after ischemic injury to a solitary kidney. J Lab Clin Med. 2001; 138(5):343-51.
150. O'Hagan HM, Mohammad HP, Baylin SB. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.
PLoS Genet. 2008; 4(8):e1000155.
135
151. Orellana M, Araya J, Guajardo V, Rodrigo R. Modulation of cytochrome P450 activity in the kidney of rats following long-term red wine exposure. Comp Biochem Physiol C Toxicol Pharmacol. 2002; 132(3):399-405.
152. Ortiz A, Justo P, Sanz A, Lorz C, Egido J. Targeting apoptosis in acute tubular injury.
Biochem Pharmacol. 2003, 15; 66(8):1589-94.
153. Ortiz AM, Troncoso P, Kahan BD. Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides. Transplant Proc. 2003; 35(4):1571-4.
154. Osley MA, Tsukuda T, Nickoloff JA. ATP-dependent chromatin remodeling factors and DNA damage repair. Mutat Res. 2007;618:65–80.
155. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol. 2003; 284(4):F608-27.
156. Pallottini V, Montanari L, Cavallini G, Bergamini E, Gori Z, Trentalance A.Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver. Mech Ageing Dev. 2004; 125(9):633-9.
157. Parthasarathy S, Wieland E, Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A. 1989;
86(3):1046-50.
158. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D, Maulik N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med. 2008;
12(6A):2350-61.
159. Peralta C, Bartrons R, Serafin A, Blazquez C, Guzman M, Prats N, Xaus C, Cutillas B, Gelpí E, Roselló-Catafau J. Adenosine monophosphate activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology. 2001; 34:1164-1173.
160. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Oliveira, R.M., Leid, M., Mcburney, M.W. And Guarente, L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPARgamma. Nature 2004; 429: 771-776.
161. Pirkkala L, Nykänen P, Sistonen L.Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 2001; 15(7):1118-31.
136
162. Prozorovski, T., Schulze-Topphoff, U., Glumm, R., Baumgart, J., Schroter, F., Ninnemann, O., Siegert, E., Bendix, I., Brustle, O., Nitsch, R. et al. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 2008; 10: 385-394.
163. Qiao X, Chen X, Wu D, Ding R, Wang J, Hong Q, Shi S, Li J, Xie Y, Lu Y, Wang Z.
Mitochondrial pathway is responsible for aging-related increase of tubular cell apoptosis in renal ischemia/reperfusion injury. J Gerontol A Biol Sci Med Sci. 2005; 60(7):830-9.
164. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev. 1999; 31(4):817-99.
165. Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res. 1991; 32(3):449- 56.
166. Ratych RE, Bulkley GB, Williams GM. Ischemia/reperfusion injury in the kidney. Prog Clin Biol Res. 1986; 224:263-89.
167. Ratych RE, Bulkley GB. Free-radical-mediated postischemic reperfusion injury in the kidney. J Free Radic Biol Med. 1986; 2(5-6):311-9.
168. Raval AP, Dave KR, Pérez-Pinzón MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab. 2006; 26(9):1141-7.
169. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, Perez-Pinzon MA.
Resveratrol and ischemic preconditioning in the brain. Curr Med Chem. 2008;15(15):1545- 51.
170. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med. 1999; 27(1-2):160-9.
171. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M.NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008; 453(7196):807-11
172. Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC-1a and SIRT1. Nature 2005;434:113–8.
173. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Bohm M. Inhibition of the
137
PDGF receptor by red wine flavonoids provides a molecular explanation for the “French Paradox”. FASEB J 2002; 16:1958-60.
174. Russell I, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest.
2004;114:495-503.
175. Sadik CD, Sies H, Schewe T. Inhibition of 15-lipoxygenase by flavonoids: structure- activity relations and mode of action. Biochem Pharmacol 2003; 65:773-81.
176. Safirstein RL. Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int Suppl. 2004; (91):S62-6.
177. Saikumar P, Venkatachalam MA Role of apoptosis in hypoxic/ischemic damage in the kidney.Semin Nephrol. 2003; 23(6):511-21.
178. Sasaki T, Maier B, Bartke A, Scrable H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell. 2006;5(5):413-22.
179. Sauve A.A., C. Wolberger, V.L. Schramm and J.D. Boeke, The biochemistry of sirtuins, Annu. Rev. Biochem. 2006, 75 pp. 435–465.
180. Schena Francesco P. and Selvaggi Francesco P. “Malattie dei reni e delle vie urinarie”
McGraw-Hill Companies, 1992.
181. Schewe T, Sadik C, Klotz L-O, Yoshimoto T, Kuhn H, Sies H. Polyphenols of cocoa:
inhibition of mammalian 15-lipoxygenase. Biol Chem 2001; 382:1687-96.
182. Schor N. Acute renal failure and the sepsis syndrome. Kidney Int 2002;61:764-776.
183. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004; 114(1):5-14. Review.
184. Schuff-Werner P, Claus G, Armstrong VW, Köstering H, Seidel D. Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis. 1989; 78(2-3):109-12.
138
185. Schumer M, Colombel MC, Sawczuk IS, Gobé G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol. 1992; 140(4):831-8.
186. Semenza GL .Expression of hypoxia-inducible factor 1: mechanisms and consequences.
Biochem Pharmacol. 2000 1;59(1):47-53.
187. Sergeev IN. Genistein induces Ca2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Biophys Res Comm 2004; 321:462-7.
188. Sesso HD, Gaziano M, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 1999; 149:162-7.
189. Sinclair DA, Guarente L. Unlocking the secrets of longevity genes. Sci. Am. 2006;294:48–
57.
190. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health--a comprehensive review of human clinical trials. Review Mol Nutr Food Res. 2011; 55(8):1129-41.
191. Spencer JP, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/PKB and ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 2003; 278:34783-93.
192. Spencer JPE, Abd El Mohsen MM, Rice-Evans C. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 2004; 423:148-61.
193. Spencer JPE, Srai SK, Rice-Evans C. Metabolism in the small intestine and gastrointestinal tract. In: Rice-Evans C, Parker L (Ed.). Flavonoids in health and disease. New York:
Marcel Dekker; 2003. p. 363-90.
194. Sperandio S, Fortin J, Sasik R, Robitaille L, Corbeil J, de Belle I .The transcription factor Egr1 regulates the HIF-1alpha gene during hypoxia. Mol Carcinog. 2009; 48(1):38-44.
195. Stevens Alan and Lowe James, “Malattie del sistema urinario” da “Patologia”, seconda edizione, casa editrice Mosby. 2001
196. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ. Resveratrol inhibits cyclooxygenase-2 transcription and
139
activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem. 1998;
273(34):21875-82.
197. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R.
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003;
278(15):12605-8.
198. Sumimoto K, Matsura T, Oku JI, Fukuda Y, Yamada K, Dohi K. Protective effect of UW solution on postischemic injury in rat liver (suppression of reduction in hepatic antioxidants during reperfusion). Transplantation. 1996; 62:1391.
199. Surh YJ, Na HK, Lee SS. Transcription factors and mitogen-activated protein kinases as molecular targets for chemoprevention with anti-inflammatory phytochemicals. Biofactors.
2004; 21(1-4): 103-8.
200. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002; 62(5):1539-49.
201. Tanaka T, Miyata T, Inagi R, Fujita T, Nangaku M. Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol. 2004; 165(6):1979-92.
202. Tanaka T, Sato H, Kita T, Tanaka N. Involvement of inducible nitric oxide synthase in renal failure after mild hemorrhage. Leg Med (Tokyo). 2004; 6(4):203-12.
203. Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I, Hirota H.
AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol. 2005; 25:9554-9575.
204. Thiagarajan RR, Winn RK, Harlan JM. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost. 1997; 78(1):310-4.
205. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors 2003;17:287-96.
206. Trojer, P. and Reinberg, D. Facultative heterochromatin: is there a distinctive molecular signature? Mol Cell 2007; 28: 1-13.
207. Uhl M, Csernok A, Aydin S, Kreienberg R, Wiesmüller L, Gatz SA.Role of SIRT1 in homologous recombination. DNA Repair (Amst). 2010;9(4):383-93.
140
208. Van Der Horst, A., Tertoolen, L.G., De Vries-Smits, L.M., Frye, R.A., Medema, R.H. And Burgering, B.M. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2 (SIRT1). J Biol Chem 2004; 279: 28873-28879.
209. Van Hoorn DEC, Nijveldt RJ, Van Leeuwen PAM, Hofman Z, M’Rabet L, De Bont DB, Van Norren K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002; 451:111-8.
210. Van Winkle DM, Chien GL, Wolff RA, Soifer BE, Kuzume K, Davis RF. Cardioprotection provided by adenosine receptor activation is abolished by blockade of KATP channel. Am J Physiol. 1994; 266:H829–H836.
211. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 2004; 16:93–105
212. Vaquero A.The conserved role of sirtuins in chromatin regulation. Int J Dev Biol.
2009;53(2-3):303-22
213. Vaquero, A., Sternglanz, R. And Reinberg, D. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 2007; 26: 5505-5520.
214. Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., Guarente, L.
And Weinberg, R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-159.
215. Vera JC, Reyes AM, Càrcamo JG, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Iribarren R, Scher HI, Slebe JC et al. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter GLUT1. J Biol Chem 1996; 271:8719-24.
216. Versteilen AM, Di Maggio F, Leemreis JR, Groeneveld AB, Musters RJ, Sipkema P.
Molecular mechanisms of acute renal failure following ischemia/reperfusion. Int J Artif Organs. 2004;27(12):1019-29.
217. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration.Life Sci. 2003; 72(20):2219-33.
218. Wallerath T, Poleo D, Li H, Fostermann U. Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial
141
cardiovascular effects. J Am Coll Cardiol 2003; 41:471-8.
219. Wang CZ, Wang Y, Di A, Magnuson MA, Ye H, Roe MW, Nelson DJ, Bell GI, Philipson LH. 5-amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Biochem Biophys Res Commun. 2005; 330(4):1073-9.
220. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix- loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A.
1995; 92(12):5510-4.
221. Way TD, Kao MC, Lin JK. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett 2005; 579:145-52.
222. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 1995; 81:323–330.
223. Weindruch R, Naylor PH, Goldstein AL, Walford RL.Influences of aging and dietary restriction on serum thymosin alpha 1 levels in mice. J Gerontol. 1988; 43(2):B40-2.
224. Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1.Science. 2009; 323(5917):1063-6
225. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II:
Review of 93 intervention studies. Am J Clin Nutr 2005; 81(Suppl.):243S-55S.
226. Winder W.W. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J. Appl. Physiol. 2001; 91:1017–1028.
227. Wiseman S, Mulder T, Rietveld A. Tea flavonoids: bioavailability in vivo and effects on cell signaling pathway in vitro. Antiox Redox Signal 2001; 3:1009-21.
228. WONG, S. and Weber, J.D. Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1. Biochem J 2007; 407: 451-460.
229. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology.1999;
30:1223–1228.
142
230. Yamamoto H, Schoonjans K, Auwerx J Sirtuin functions in health and disease. Mol Endocrinol. 2007; 21(8):1745-55.
231. Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A. And Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380.
232. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999; 149:943-9.
233. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB. Human, rat, and mouse metabolism of resveratrol. Pharm Res.
2002; 19(12):1907-14.
234. Yuan, Z., Zhang, X., Sengupta, N., Lane, W.S. And Seto, E. SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell 2007; 27: 149-162.
235. Zhang Jiandi. Resveratrol inhibits insulin responses in a SirT1-independent pathway.
Biochem. J. (2006) 397 (519–527).
